Research training and capacity building in low- and middle-income countries (LMIC) have been critical to understanding and effectively preventing and treating HIV infection and AIDS. This session will highlight successes and lessons learned from training and capacity programs over the past three decades and stimulate discussion on future activities to local ownership and sustainability. The panel will feature early-career current of recent LMIC trainees as well as LMIC senior mentors and organizational heads who can talk about needs and opportunities that can be harnessed for sustained growth of the research environment. The symposium is organized by the Fogarty International Center of the U.S. National Institutes of Health, which has been supporting HIV research training for more than 30 years, and is seeking input for continued support of the research training and capacity building efforts.

Join this live discussion in which the expert panel explores the latest issues relating to HIV care through cases and expert dialogue followed by dedicated time to answer your questions. Topics covered will focus on key areas of HIV management, including optimal use of newer antiretroviral agents and strategies, individualizing ART for women of childbearing potential and during pregnancy, the impact of evolving data on adverse events during ART, and the anticipated roles of emerging and investigational novel ART strategies. Supported by an educational grant from Merck Sharp & Dohme Corp.

Multisectoral alliances and partnerships continue to shape global responses to HIV. What are the secrets to success of these partnerships? How can current models be built on to create new collaborations? The push to end the HIV epidemic as a public health threat by 2030 will require closing gaps in HIV prevention and treatment. Through multisector alliances, we can leverage the strengths of a range of partners. In this panel discussion, moderator Vignetta Charles, PhD and CEO at ETR, will pose some key questions to the following panelists on their experiences as stakeholders: Dr Angeli Achreker, Principal Deputy US Global AIDS Co-ordinator (PEPFAR) on DREAMS; Lauren Marks, Director of Private Sector Engagement at PEPFAR on MenStar Coalition; Anne Aslett, Director of the Elton John AIDS Foundation on RADIAN; Shanell McGoy, Associate Director of Corporate Social Responsibility at Gilead Sciences on COMPASS Initiative; and Alex Kalomparis, Vice President for Public Affairs, International, Gilead Sciences, Inc. The panelists, who will take live questions from the audience, will share some of the lessons they’ve learned, discuss how partnerships actually function at ground level, and offer advice on how they can truly support the needs of the communities they serve.

Review key developments in ART management. This set of concise, on-demand talks from leading HIV faculty highlights how to (1) select among newer antiretrovirals and treatment paradigms, (2) individualize ART for women of childbearing potential and during pregnancy, (3) incorporate evolving data on ART-associated adverse events into patient care, and (4) anticipate the role of emerging investigational ART strategies. Watch these prerecorded foundational snippets to set the stage for a live case-based panel discussion on July 7. Supported by an educational grant from Merck Sharp & Dohme Corp.

Research training and capacity building in low- and middle-income countries (LMIC) have been critical to understanding and effectively preventing and treating HIV infection and AIDS. This session will highlight successes and lessons learned from training and capacity programs over the past three decades and stimulate discussion on future activities to local ownership and sustainability. The panel will feature early-career current of recent LMIC trainees as well as LMIC senior mentors and organizational heads who can talk about needs and opportunities that can be harnessed for sustained growth of the research environment. The symposium is organized by the Fogarty International Center of the U.S. National Institutes of Health, which has been supporting HIV research training for more than 30 years, and is seeking input for continued support of the research training and capacity building efforts.

Join this live discussion in which the expert panel explores the latest issues relating to HIV care through cases and expert dialogue followed by dedicated time to answer your questions. Topics covered will focus on key areas of HIV management, including optimal use of newer antiretroviral agents and strategies, individualizing ART for women of childbearing potential and during pregnancy, the impact of evolving data on adverse events during ART, and the anticipated roles of emerging and investigational novel ART strategies. Supported by an educational grant from Merck Sharp & Dohme Corp.

Multisectoral alliances and partnerships continue to shape global responses to HIV. What are the secrets to success of these partnerships? How can current models be built on to create new collaborations? The push to end the HIV epidemic as a public health threat by 2030 will require closing gaps in HIV prevention and treatment. Through multisector alliances, we can leverage the strengths of a range of partners. In this panel discussion, moderator Vignetta Charles, PhD and CEO at ETR, will pose some key questions to the following panelists on their experiences as stakeholders: Dr Angeli Achreker, Principal Deputy US Global AIDS Co-ordinator (PEPFAR) on DREAMS; Lauren Marks, Director of Private Sector Engagement at PEPFAR on MenStar Coalition; Anne Aslett, Director of the Elton John AIDS Foundation on RADIAN; Shanell McGoy, Associate Director of Corporate Social Responsibility at Gilead Sciences on COMPASS Initiative; and Alex Kalomparis, Vice President for Public Affairs, International, Gilead Sciences, Inc. The panelists, who will take live questions from the audience, will share some of the lessons they’ve learned, discuss how partnerships actually function at ground level, and offer advice on how they can truly support the needs of the communities they serve.